The current valuation score of Ionis Pharmaceuticals Inc is 9.16, ranking 53 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -36.71, which is -76.68% below the recent high of -8.56 and -46.56% above the recent low of -53.80.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.